Related Experiment Video
Updated: Aug 25, 2025

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
20.8K
To fit or not to fit: death decisions from morphogen fields
Marisa M Merino1, Marcos Gonzalez-Gaitan1
1Department of Biochemistry, Faculty of Sciences, University of Geneva, Geneva, Switzerland.
Trends in Cell Biology
|October 14, 2022
Summary
Transforming growth factor-β (TGF-β) morphogens create concentration gradients that scale with organ size. Cell death can also mediate this scaling, a mechanism potentially used by cancer cells.
Area of Science:
- Developmental Biology
- Cell Biology
- Cancer Biology
Background:
- Transforming growth factor-β (TGF-β)-type morphogens are crucial signaling molecules conserved across the animal kingdom.
- These molecules establish concentration gradients that are essential for organ development and scaling.
- The precise mechanisms regulating morphogen gradient scaling are critical for understanding tissue development and disease.
Purpose of the Study:
- To investigate the role of cell death in scaling morphogen gradients.
- To explore the potential exploitation of death-mediated scaling mechanisms by cancer cells.
Main Methods:
- This study focuses on theoretical and conceptual analysis of morphogen gradient dynamics.
- It integrates principles of developmental biology and cell death pathways.
Main Results:
- Morphogen gradients, such as those involving TGF-β, scale with the size of developing organs.
- Cell death emerges as a significant factor in regulating the spatial range of these morphogen gradients.
- This death-mediated scaling adjusts tissue size to the functional range of the morphogen gradient.
Conclusions:
- Cell death provides a mechanism for scaling morphogen gradients, ensuring proper tissue size regulation.
- Cancer cells may co-opt these endogenous death-mediated scaling processes for their own growth and proliferation.
Related Concept Videos
Morphogenesis
28.7K
Plant morphogenesis—the development of a plant’s form and structure—involves several overlapping developmental processes, including growth and cell differentiation. Precursor cells differentiate into specific cell types, which are organized into the tissues and organ systems that make up the functional plant.
28.7K
Determination
18.9K
During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
18.9K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Forced Transdifferentiation
2.0K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.0K
Apoptosis
11.8K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.8K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K

